Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-24 @ 5:03 PM
NCT ID:
NCT04022850
Eligibility Criteria:
Eligibility for professionals:
* FPs belonging to any of the 13 Integrated Healthcare Organizations of Osakidetza
* Non-zero annual incidence rate of PIP of statins at baseline (2021)
* A minimum cluster size of n ≥10 patients
Eligibility for patients:
* 40- to 74-year-old men and 45- to 74-year-old women
* No history of statin use
* LDL cholesterol levels between 70 and 189 mg/dL and/or TC between 200 and 289 mg/dL
* Without ischemic heart disease/CVD
* Estimated CVR REGICOR \<7.5%
* Attend at least one appointment at the participating FPs' practices during the study period from May 2022 to May 2023, and followed until May 2024
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT04022850
Study Brief:
Protocol Section:
NCT04022850